Maternal DHA Supplementation and Offspring Neurodevelopment in India (DHANI-2) (DHANI-2)
Maternal Docosa-Hexaenoic Acid (DHA) Supplementation and Offspring Neurodevelopment in India (DHANI-2)
Sponsor: India Alliance
A PHASE3 clinical study on Pregnancy, this trial is completed. The trial is conducted by India Alliance and has accumulated 11 data snapshots since 2015. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
11 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Apr 2021 — Jul 2024 [monthly]
Completed PHASE3
Status: Active Not Recruiting → Completed
-
Jan 2021 — Apr 2021 [monthly]
Active Not Recruiting PHASE3
▶ Show 6 earlier versions
-
Feb 2020 — Jan 2021 [monthly]
Active Not Recruiting PHASE3
-
Sep 2019 — Feb 2020 [monthly]
Active Not Recruiting PHASE3
-
Apr 2019 — Sep 2019 [monthly]
Active Not Recruiting PHASE3
-
Jun 2018 — Apr 2019 [monthly]
Active Not Recruiting PHASE3
-
Oct 2017 — Jun 2018 [monthly]
Active Not Recruiting PHASE3
Status: Recruiting → Active Not Recruiting
-
May 2017 — Oct 2017 [monthly]
Recruiting PHASE3
First recorded
Dec 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- India Alliance
- Jawaharlal Nehru Medical College
- Public Health Foundation of India
For direct contact, visit the study record on ClinicalTrials.gov .